Market Risers: AstraZeneca, BP, Caledonia Mining Corporation

Broker Ratings

The stock price for AstraZeneca with company EPIC: LON:AZN has stepped up 1.22% or 91.57 points throughout the session so far. Market buyers have remained positive while the stock has been in play. The periods high figure was 7646.76 while the low for the session was 7543. The total volume of shares traded by this point was 549,400 with the daily average number around 2,952,061. The 52 week high for the shares is 10120 about 2590 points in difference on the previous days close and a 52 week low being 6736 is a variance of 794 points. AstraZeneca now has a 20 SMA of 7516.08 and now its 50 day moving average now at 7316.47. The current market capitalisation is £99,893.01m at the time of this report. The currency for this stock is GBX. Market cap is measured in GBP. This article was written with the last trade for AstraZeneca being recorded at Tuesday, April 27, 2021 at 12:20:25 PM GMT with the stock price trading at 7621.57 GBX.

The share price for BP with company EPIC: LON:BP has risen 1.37% or 4.05 points throughout today’s trading session so far. Traders have so far held a positive outlook throughout the session. The periods high figure was 307.45 dipping to 296. The total volume of shares traded by this point was 20,429,440 with the daily average traded share volume around 51,478,434. The 52 week high for the shares is 508.7 around 212.15 points difference from the previous days close and the 52 week low at 188.52 which is a difference of 108.03 points. BP now has a 20 simple moving average of 302.91 and now its 50 day SMA of 304.71. The market capitalisation is now £61,069.15m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for BP being recorded at Tuesday, April 27, 2021 at 12:20:36 PM GMT with the stock price trading at 300.6 GBX.

The trading price for Caledonia Mining Corporation found using EPIC: LON:CMCL has moved up 4.55% or 50 points throughout today’s trading session so far. Market buyers are a positive bunch while the stock has been in play. The periods high has reached 1150 meanwhile the session low reached 1050. The volume total for shares traded up to this point was 566 with the average number of shares traded daily being 5,327. The 52 week high price for the shares is 1900 amounting to 800 points difference from the previous days close and the 52 week low at 950 a difference of some 150 points. Caledonia Mining Corporation now has a 20 SMA at 1134.19 and also a 50 day simple moving average now at 1141.77. Market capitalisation for the company is £170.39m at the time of this report. The share price is in GBX. Mcap is measured in GBP. This article was written with the last trade for Caledonia Mining Corporation being recorded at Tuesday, April 27, 2021 at 9:59:02 AM GMT with the stock price trading at 1150 GBX.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

AstraZeneca wins US approval for Imfinzi in early gastric and GEJ cancers

AstraZeneca has received US approval for Imfinzi combined with FLOT chemotherapy for adults with resectable early-stage and locally advanced gastric and gastroesophageal junction cancers.

AstraZeneca Plc to invest $2 billion in major Maryland manufacturing expansion

AstraZeneca has confirmed a $2 billion investment to expand its manufacturing presence in Maryland, including a larger biologics facility in Frederick and a new clinical manufacturing site in Gaithersburg.

BP Plc delivers strong Q3 earnings and strategic progress

BP reported a solid third quarter in 2025 with underlying replacement cost profit of $2.2 billion and operating cash flow of $7.8 billion, supported by improved upstream reliability and downstream profitability.

AstraZeneca Tezspire approved in the US for chronic rhinosinusitis with nasal polyps

The US FDA has approved AstraZeneca and Amgen’s Tezspire (tezepelumab) as an add-on maintenance treatment for patients aged 12 and over with inadequately controlled chronic rhinosinusitis with nasal polyps.

BP Plc reports higher production and stable debt in Q3 2025 update

BP has issued its third-quarter 2025 trading statement, expecting higher upstream production compared with the previous quarter, driven by increased gas output from bpx energy.

AstraZeneca Plc reaches agreement with Trump administration to cut US drug prices

AstraZeneca has signed a landmark agreement with President Donald J. Trump’s administration to reduce the cost of prescription medicines for American patients.

Search

Search